271 – 280 of 630
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Immunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B - a systematic literature review
(
- Contribution to journal › Scientific review
-
Mark
Inflammatory plasma markers and risk for venous thromboembolism.
(
- Contribution to journal › Article
-
Mark
Angiogenesis is increased in advanced haemophilic joint disease and characterized by normal pericyte coverage.
(
- Contribution to journal › Article
-
Mark
Outcome measures in haemophilia: a systematic review
(
- Contribution to journal › Scientific review
-
Mark
Switching clotting factor concentrates: considerations in estimating the risk of immunogenicity
(
- Contribution to journal › Article
-
Mark
Atrial fibrillation patients do not benefit from acetylsalicylic acid
(
- Contribution to journal › Article
-
Mark
The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A
(
- Contribution to journal › Article
-
Mark
Red cell distribution width and risk for venous thromboembolism: A population-based cohort study.
(
- Contribution to journal › Article
-
Mark
Pharmacokinetics, phenotype and product choice in haemophilia B: how to strike a balance?
(
- Contribution to journal › Article
-
Mark
Introduction.
(
- Contribution to journal › Article